Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for peptidase C01.075: cruzipain

Summary Alignment Sequences Sequence features Distribution Structure Literature Substrates Pharma

(Topics flags: S Structure, T Target, P Specificity, I Inhibitor, E Expression, U Therapeutic, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2025
  1. Cerutti,J.P., Diniz,L.A., Correa Santos,V., Vilchez Larrea,S.C., Alonso,G.D., Ferreira,R.S., Quevedo,M.A. and Dehaen,W.
    Discovery of a Potent Triazole-Based Reversible Targeted Covalent Inhibitor of Cruzipain
    ACS Med Chem Lett (2025) 16, 72-79. PubMed  Europe PubMed DOI  PMC  EPMC  I
  2. Cerutti,J.P., Estrada Canepa,J.I., Diniz,L.A., Vilchez Larrea,S.C., Santos,V.C., Alonso,G.D., Ferreira,R.S., Dehaen,W. and Quevedo,M.A.
    Structure-Based Discovery of Non-Covalent Triazole-Based Cruzipain Inhibitors with Improved Bioactivity Translation
    J Chem Inf Model (2025) PubMed  Europe PubMed DOI  I
  3. Sheu-Idrees,R., Marques,G.V.L., Santana,P.A.L., Diniz,L.A., Resende,D.M., Odoma,S., Olorunshola,O., Ferreira,R.S., Murta,S.M.F., Maltarollo,V.G. and de Oliveira,R.B.
    Investigation of the activity of 4-aminoquinolines as cysteine protease inhibitors with application in the treatment of Chagas disease
    Mem Inst Oswaldo Cruz (2025) 120, e240161-e240161. PubMed  Europe PubMed DOI  PMC  EPMC  I
    4. 2024
  4. Cerutti,J.P., Diniz,L.A., Santos,V.C., Vilchez Larrea,S.C., Alonso,G.D., Ferreira,R.S., Dehaen,W. and Quevedo,M.A.
    Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain
    Molecules (2024) 29 PubMed  Europe PubMed DOI  PMC  EPMC
  5. Prates,J.L.B., Lopes,J.R., Chin,C.M., Ferreira,E.I., Dos Santos,J.L. and Scarim,C.B.
    Discovery of Novel Inhibitors of Cruzain Cysteine Protease of Trypanosoma cruz
    Curr Med Chem (2024) 31, 2285-2308. PubMed  Europe PubMed DOI  V
    6. 2023
  6. Santos,V.C., Leite,P.G., Santos,L.H., Pascutti,P.G., Kolb,P., Machado,F.S. and Ferreira,R.S.
    Structure-based discovery of novel cruzain inhibitors with distinct trypanocidal activity profiles
    Eur J Med Chem (2023) 257, 115498-115498. PubMed  Europe PubMed DOI  I
    7. 2022
  7. de Oliveira,A.S., Valli,M., Ferreira,L.L., Souza,J.M., Krogh,R., Meier,L., Abreu,H.R., Voltolini,B.G., Llanes,L.C., Nunes,R.J., Braga,A.L. and Andricopulo,A.D.
    Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies
    Future Med Chem (2022) 14, 795-808. PubMed  Europe PubMed DOI  I
  8. Reis,C.R.C.D., Souza,H.V.C.M., Leme,R.P.P., Castelo-Branco,F.S., Fernandes,T.V.A., Boechat,N., Dias,L.R.S. and Hoelz,L.V.B.
    Study of the dynamic behavior of the cruzain enzyme in free and complexed forms with competitive and noncovalent benzimidazole inhibitors
    J Biomol Struct Dyn (2022) , 1-15. PubMed  Europe PubMed DOI
  9. Santos,V.C. and Ferreira,R.S.
    Computational approaches towards the discovery and optimisation of cruzain inhibitors
    Mem Inst Oswaldo Cruz (2022) 117, e210385-e210385. PubMed  Europe PubMed DOI  PMC  EPMC  V
    10. 2021
  10. Barbosa da Silva,E., Rocha,D.A., Fortes,I.S., Yang,W., Monti,L., Siqueira-Neto,J.L., Caffrey,C.R., McKerrow,J., Andrade,S.F. and Ferreira,R.S.
    Structure-Based Optimization of Quinazolines as Cruzain and TbrCATL Inhibitors
    J Med Chem (2021) 64, 13054-13071. PubMed  Europe PubMed DOI  I
  11. Santos Nascimento,I.J.D., de Aquino,T.M. and da Silva-Junior,E.F.
    Cruzain and Rhodesain Inhibitors: Last Decade of Advances in Seeking for New Compounds Against American and African Trypanosomiases
    Curr Top Med Chem (2021) PubMed  Europe PubMed DOI  V
  12. Valois,M.V., de Oliveira,C., Lapa,A.J., Souccar,C. and Oliva,M.L.V.
    Bauhinia Protease Inhibitors Attenuate Gastric Ulcer by Blocking Neutrophil Enzymes
    Planta Med (2021) 87, 169-176. PubMed  Europe PubMed DOI
    13. 2020
  13. Alvarez,V.E., Iribarren,P.A., Niemirowicz,G.T. and Cazzulo,J.J.
    Update on relevant trypanosome peptidases: Validated targets and future challenges
    Biochim Biophys Acta Proteins Proteom (2020) 1869, 140577-140577. PubMed  Europe PubMed DOI
  14. Arafet,K., Gonzalez,F.V. and Moliner,V.
    Quantum mechanics/molecular mechanics studies of the mechanism of cysteine proteases inhibition by dipeptidyl nitroalkenes
    Chemistry (2020) 26, 2002-2012. PubMed  Europe PubMed DOI  I
  15. Bonatto,V., Batista,P.H.J., Cianni,L., De Vita,D., Silva,D.G., Cedron,R., Tezuka,D.Y., de Albuquerque,S., Moraes,C.B., Franco,C.H., Lameira,J., Leitao,A. and Montanari,C.A.
    On the intrinsic reactivity of highly potent trypanocidal cruzain inhibitors
    RSC Med Chem (2020) 11, 1275-1284. PubMed  Europe PubMed DOI  PMC  EPMC  I
  16. Cerny,N., Bivona,A.E., Sanchez Alberti,A., Trinitario,S.N., Morales,C., Cardoso Landaburu,A., Cazorla,S.I. and Malchiodi,E.L.
    Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against Trypanosoma cruzi
    Front Immunol (2020) 11, 565142-565142. PubMed  Europe PubMed DOI  PMC  EPMC
  17. Chenna,B.C., Li,L., Mellott,D.M., Zhai,X., Siqueira-Neto,J.L., Calvet Alvarez,C., Bernatchez,J.A., Desormeaux,E., Alvarez Hernandez,E., Gomez,J., McKerrow,J.H., Cruz-Reyes,J. and Meek,T.D.
    Peptidomimetic vinyl heterocyclic inhibitors of cruzain effect anti-trypanosomal activity
    J Med Chem (2020) 63, 3298-3316. PubMed  Europe PubMed DOI  I
  18. Cianni,L., Lemke,C., Gilberg,E., Feldmann,C., Rosini,F., Rocho,F.D.R., Ribeiro,J.F.R., Tezuka,D.Y., Lopes,C.D., de Albuquerque,S., Bajorath,J., Laufer,S., Leitao,A., Gutschow,M. and Montanari,C.A.
    Mapping the S1 and S1' subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents
    PLoS Negl Trop Dis (2020) 14, e0007755-e0007755. PubMed  Europe PubMed DOI  I
  19. Cianni,L., Rocho,F.D.R., Rosini,F., Bonatto,V., Ribeiro,J.F.R., Lameira,J., Leitao,A., Shamim,A. and Montanari,C.A.
    Optimization strategy of single-digit nanomolar cross-class inhibitors of mammalian and protozoa cysteine proteases
    Bioorg Chem (2020) 101, 104039-104039. PubMed  Europe PubMed DOI  I
  20. de Souza,M.L., de Oliveira Rezende Junior,C., Ferreira,R.S., Espinoza Chavez,R.M., Ferreira,L.L.G., Slafer,B.W., Magalhaes,L.G., Krogh,R., Oliva,G., Cruz,F.C., Dias,L.C. and Andricopulo,A.D.
    Discovery of potent, reversible and competitive cruzain inhibitors with trypanocidal activity: a structure-based drug design approach
    J Chem Inf Model (2020) 60, 1028-1041. PubMed  Europe PubMed DOI  I
  21. Fonseca Lameiro,R.D., Shamim,A., Rosini,F., Cendron,R., Jatai Batista,P.H. and Montanari,C.A.
    Synthesis, biochemical evaluation and molecular modeling studies of nonpeptidic nitrile-based fluorinated compounds
    Future Med Chem (2020) PubMed  Europe PubMed DOI
  22. Ribeiro,J.F.R., Cianni,L., Li,C., Warwick,T.G., De Vita,D., Rosini,F., Dos Reis Rocho,F., Martins,F.C.P., Kenny,P.W., Lameira,J., Leitao,A., Emsley,J. and Montanari,C.A.
    Crystal structure of Leishmania mexicana cysteine protease B in complex with a high-affinity azadipeptide nitrile inhibitor
    Bioorg Med Chem (2020) 28, 115743-115743. PubMed  Europe PubMed DOI  I
  23. Silva,J.R.A., Cianni,L., Araujo,D., Batista,P.H.J., De Vita,D., Rosini,F., Leitao,A., Lameira,J. and Montanari,C.A.
    Assessment of the cruzain cysteine protease reversible and irreversible covalent inhibition mechanism
    J Chem Inf Model (2020) 60, 1666-1677. PubMed  Europe PubMed DOI  I
  24. Toman,N.P., Kamenik,A.S., Santos,L.H., Hofer,F., Liedl,K.R. and Ferreira,R.S.
    Profiling selectivity of chagasin mutants towards cysteine proteases cruzain or cathepsin L through molecular dynamics simulations
    J Biomol Struct Dyn (2020) , 1-13. PubMed  Europe PubMed DOI
    25. 2019
  25. Barbosa da Silva,E., Dall,E., Briza,P., Brandstetter,H. and Ferreira,R.S.
    Cruzain structures: apocruzain and cruzain bound to S-methyl thiomethanesulfonate and implications for drug design
    Acta Crystallogr F Struct Biol Commun (2019) 75, 419-427. PubMed  Europe PubMed DOI  S
  26. Bhowmick,S., Chorge,R.D., Jangam,C.S., Bharatrao,L.D., Patil,P.C., Chikhale,R.V. and Islam,M.A.
    Identification of potential cruzain inhibitors using de novo design, molecular docking and dynamics simulations studies
    J Biomol Struct Dyn (2019) , 1-11. PubMed  Europe PubMed DOI  I
  27. Boudreau,P.D., Miller,B.W., McCall,L.I., Almaliti,J., Reher,R., Hirata,K., Le,T., Siqueira-Neto,J.L., Hook,V. and Gerwick,W.H.
    Design of gallinamide A analogs as potent inhibitors of the cysteine proteases human cathepsin L and Trypanosoma cruzi cruzain
    J Med Chem (2019) 62, 9026-9044. PubMed  Europe PubMed DOI  I
  28. Cianni,L., Feldmann,C.W., Gilberg,E., Gutschow,M., Juliano,L., Leitao,A., Bajorath,J. and Montanari,C.A.
    Can cysteine protease cross-class inhibitors achieve selectivity?
    J Med Chem (2019) 62, 10497-10525. PubMed  Europe PubMed DOI  I
  29. Fabian,L., Martini,M.F., Sarduy,E.S., Estrin,D.A. and Moglioni,A.G.
    Evaluation of quinoxaline compounds as ligands of a site adjacent to S2 (AS2) of cruzain
    Bioorg Med Chem Lett (2019) 29, 2197-2202. PubMed  Europe PubMed DOI  I
  30. Ferreira,R.A.A., Pauli,I., Sampaio,T.S., de Souza,M.L., Ferreira,L.L.G., Magalhaes,L.G., Rezende CO Jr, Ferreira,R.S., Krogh,R., Dias,L.C. and Andricopulo,A.D.
    Structure-based and molecular modeling studies for the discovery of cyclic imides as reversible cruzain inhibitors with potent anti-Trypanosoma cruzi activity
    Front Chem (2019) 7, 798-798. PubMed  Europe PubMed DOI  PMC  EPMC  I
  31. Gomes,J.C., Cianni,L., Ribeiro,J., Dos Reis Rocho,F., da Costa Martins Silva,S., Batista,P.H.J., Moraes,C.B., Franco,C.H., Freitas-Junior,L.H.G., Kenny,P.W., Leitao,A., Burtoloso,A.C.B., De Vita,D. and Montanari,C.A.
    Synthesis and structure-activity relationship of nitrile-based cruzain inhibitors incorporating a trifluoroethylamine-based P2 amide replacement
    Bioorg Med Chem (2019) , 115083-115083. PubMed  Europe PubMed DOI  I
  32. Hernandez Alvarez,L., Barreto Gomes,D.E., Hernandez Gonzalez,J.E. and Pascutti,P.G.
    Dissecting a novel allosteric mechanism of cruzain: a computer-aided approach
    PLoS ONE (2019) 14, e0211227-e0211227. PubMed  Europe PubMed DOI  PMC  EPMC
  33. Herrera-Mayorga,V., Lara-Ramirez,E.E., Chacon-Vargas,K.F., Aguirre-Alvarado,C., Rodriguez-Paez,L., Alcantara-Farfan,V., Cordero-Martinez,J., Nogueda-Torres,B., Reyes-Espinosa,F., Bocanegra-Garcia,V. and Rivera,G.
    Structure-based virtual screening and in vitro evaluation of new Trypanosoma cruzi cruzain inhibitors
    Int J Mol Sci (2019) 20 PubMed  Europe PubMed DOI  I
  34. Luchi,A.M., Villafane,R.N., Gomez Chavez,J.L., Bogado,M.L., Angelina,E.L. and Peruchena,N.M.
    Combining charge density analysis with machine learning tools to investigate the cruzain inhibition mechanism
    ACS Omega (2019) 4, 19582-19594. PubMed  Europe PubMed DOI  PMC  EPMC  I
  35. Monteiro,M.E., Lechuga,G., Lara,L.S., Souto,B.A., Vigano,M.G., Bourguignon,S.C., Calvet,C.M., Oliveira,F.O.R., Jr., Alves,C.R., Souza-Silva,F., Santos,M.S. and Pereira,M.C.S.
    Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease
    Eur J Med Chem (2019) 182, 111610-111610. PubMed  Europe PubMed DOI  I
  36. Reyes-Espinosa,F., Juarez-Saldivar,A., Palos,I., Herrera-Mayorga,V., Garcia-Perez,C. and Rivera,G.
    In silico analysis of homologous heterodimers of cruzipain-chagasin from structural models built by homology
    Int J Mol Sci (2019) 20 PubMed  Europe PubMed DOI
  37. Santos,L.H., Waldner,B.J., Fuchs,J.E., Pereira,G.A.N., Liedl,K.R., Caffarena,E.R. and Ferreira,R.S.
    Understanding structure-activity relationships for trypanosomal cysteine protease inhibitors by simulations and free energy calculations
    J Chem Inf Model (2019) 59, 137-148. PubMed  Europe PubMed DOI  I
  38. Sartori,G.R., Leitao,A., Montanari,C.A. and Laughton,C.A.
    Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors
    PLoS ONE (2019) 14, e0222055-e0222055. PubMed  Europe PubMed DOI  I
  39. Vieira,R.P., Santos,V.C. and Ferreira,R.S.
    Structure-based approaches targeting parasite cysteine proteases
    Curr Med Chem (2019) 26, 4435-4453. PubMed  Europe PubMed DOI  I
    40. 2018
  40. Cianni,L., Sartori,G., Rosini,F., De Vita,D., Pires,G., Lopes,B.R., Leitao,A., Burtoloso,A.C.B. and Montanari,C.A.
    Leveraging the cruzain S3 subsite to increase affinity for reversible covalent inhibitors
    Bioorg Chem (2018) 79, 285-292. PubMed  Europe PubMed DOI  I
  41. da Silva-Junior,E.F., Barcellos Franca,P.H., Ribeiro,F.F., Bezerra Mendonca-Junior,F.J., Scotti,L., Scotti,M.T., de Aquino,T.M. and de Araujo-Junior,J.X.
    Molecular docking studies applied to a dataset of cruzain inhibitors
    Curr Comput Aided Drug Des (2018) 14, 68-78. PubMed  Europe PubMed DOI  I
  42. Dos Santos,A.M., Cianni,L., De Vita,D., Rosini,F., Leitao,A., Laughton,C.A., Lameira,J. and Montanari,C.A.
    Experimental study and computational modelling of cruzain cysteine protease inhibition by dipeptidyl nitriles
    Phys Chem Chem Phys (2018) 20, 24317-24328. PubMed  Europe PubMed DOI  I
  43. Giroud,M., Dietzel,U., Anselm,L., Banner,D., Kuglstatter,A., Benz,J., Blanc,J.B., Gaufreteau,D., Liu,H., Lin,X., Stich,A., Kuhn,B., Schuler,F., Kaiser,M., Brun,R., Schirmeister,T., Kisker,C., Diederich,F. and Haap,W.
    Repurposing a library of human cathepsin L ligands: identification of macrocyclic lactams as potent rhodesain and Trypanosoma brucei inhibitors
    J Med Chem (2018) 61, 3350-3369. PubMed  Europe PubMed DOI  S  I
  44. Martins,L.C., Torres,P.H.M., de Oliveira,R.B., Pascutti,P.G., Cino,E.A. and Ferreira,R.S.
    Investigation of the binding mode of a novel cruzain inhibitor by docking, molecular dynamics, ab initio and MM/PBSA calculations
    J Comput Aided Mol Des (2018) 32, 591-605. PubMed  Europe PubMed DOI  I
  45. Rocha,D.A., Silva,E.B., Fortes,I.S., Lopes,M.S., Ferreira,R.S. and Andrade,S.F.
    Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors
    Eur J Med Chem (2018) 157, 1426-1459. PubMed  Europe PubMed DOI  I
  46. Royo,S., Schirmeister,T., Kaiser,M., Jung,S., Rodriguez,S., Bautista,J.M. and Gonzalez,F.V.
    Antiprotozoal and cysteine proteases inhibitory activity of dipeptidyl enoates
    Bioorg Med Chem (2018) 26, 4624-4634. PubMed  Europe PubMed DOI  I
  47. Salas-Sarduy,E., Landaburu,L.U., Karpiak,J., Madauss,K.P., Cazzulo,J.J., Aguero,F. and Alvarez,V.E.
    Author Correction: Novel scaffolds for inhibition of cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxes
    Sci Rep (2018) 8, 8743-8743. PubMed  Europe PubMed DOI  PMC  EPMC  I
  48. Saraiva,A.P.B., Miranda,R.M., Valente,R.P.P., Araujo,J.O., Souza,R.N.B., Costa,C.H.S., Oliveira,A.R.S., Almeida,M.O., Figueiredo,A.F., Ferreira,J.E.V., Alves,C.N. and Honorio,K.M.
    Molecular description of alpha-keto-based inhibitors of cruzain with activity against Chagas disease combining 3D-QSAR studies and molecular dynamics
    Chem Biol Drug Des (2018) 92, 1475-1487. PubMed  Europe PubMed DOI  I
  49. Serrano,M., Gonzalez,V., Ray,S., Chavez,M.D. and Narayan,M.
    Identification of structure-stabilizing interactions in enzymes: a novel mechanism to impact enzyme activity
    Cell Biochem Biophys (2018) 76, 59-71. PubMed  Europe PubMed DOI
  50. Zhai,X. and Meek,T.D.
    Catalytic mechanism of cruzain from Trypanosoma cruzi as determined from solvent kinetic isotope effects of steady-state and pre-steady-state kinetics
    Biochemistry (2018) 57, 3176-3190. PubMed  Europe PubMed DOI
    51. 2017
  51. Braga,S.F., Martins,L.C., da Silva,E.B., Sales Junior,P.A., Murta,S.M., Romanha,A.J., Soh,W.T., Brandstetter,H., Ferreira,R.S. and de Oliveira,R.B.
    Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification
    Bioorg Med Chem (2017) 25, 1889-1900. PubMed  Europe PubMed DOI  I
  52. Burtoloso,A.C., de Albuquerque,S., Furber,M., Gomes,J.C., Goncalez,C., Kenny,P.W., Leitao,A., Montanari,C.A., Quilles JC Junior, Ribeiro,J.F. and Rocha,J.R.
    Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors
    PLoS Negl Trop Dis (2017) 11, e0005343-e0005343. PubMed  Europe PubMed DOI  I
  53. de Souza,A.S., de Oliveira,M.T. and Andricopulo,A.D.
    Development of a pharmacophore for cruzain using oxadiazoles as virtual molecular probes: quantitative structure-activity relationship studies
    J Comput Aided Mol Des (2017) 31, 801-816. PubMed  Europe PubMed DOI  I
  54. Ferreira,L.G. and Andricopulo,A.D.
    Targeting cysteine proteases in trypanosomatid disease drug discovery
    Pharmacol Ther (2017) 180, 49-61. PubMed  Europe PubMed DOI  T
  55. Palos,I., Lara-Ramirez,E.E., Lopez-Cedillo,J.C., Garcia-Perez,C., Kashif,M., Bocanegra-Garcia,V., Nogueda-Torres,B. and Rivera,G.
    Repositioning FDA drugs as potential cruzain inhibitors from Trypanosoma cruzi: virtual screening, In vitro and in vivo studies
    Molecules (2017) 22 PubMed  Europe PubMed DOI  I
  56. Pauli,I., Ferreira,L.G., de Souza,M.L., Oliva,G., Ferreira,R.S., Dessoy,M.A., Slafer,B.W., Dias,L.C. and Andricopulo,A.D.
    Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors
    Future Med Chem (2017) 9, 641-657. PubMed  Europe PubMed DOI  I
  57. Salas-Sarduy,E., Landaburu,L.U., Karpiak,J.X., Madauss,K.P., Cazzulo,J.J., Aguero,F. and Alvarez,V.E.
    Novel scaffolds for inhibition of cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxes
    Sci Rep (2017) 7, 12073-12073. PubMed  Europe PubMed DOI  I
  58. Silva,D.G., Ribeiro,J.F.R., De Vita,D., Cianni,L., Franco,C.H., Freitas-Junior,L.H., Moraes,C.B., Rocha,J.R., Burtoloso,A.C.B., Kenny,P.W., Leitao,A. and Montanari,C.A.
    A comparative study of warheads for design of cysteine protease inhibitors
    Bioorg Med Chem Lett (2017) 27, 5031-5035. PubMed  Europe PubMed DOI  I
  59. Silva,D.G., Rocha,J.R., Sartori,G.R. and Montanari,C.A.
    Highly predictive hologram QSAR models of nitrile-containing cruzain inhibitors
    J Biomol Struct Dyn (2017) 35, 3232-3249. PubMed  Europe PubMed DOI  I
    60. 2016
  60. Cerny,N., Sanchez Alberti,A., Bivona,A.E., De Marzi,M.C., Frank,F.M., Cazorla,S.I. and Malchiodi,E.L.
    Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection
    Hum Vaccin Immunother (2016) 12, 438-450. PubMed  Europe PubMed DOI  U
  61. de Moraes Gomes,P.A., de Oliveira Barbosa,M., Farias Santiago,E., de Oliveira Cardoso,M.V., Capistrano Costa,N.T., Hernandes,M.Z., Moreira,D.R., Da Silva,A.C., Dos Santos,T.A., Pereira,V.R., Brayner Dos Santosd,F.A., do Nascimento Pereira,G.A., Ferreira,R.S. and Leite,A.C.
    New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi
    Eur J Med Chem (2016) 121, 387-398. PubMed  Europe PubMed DOI  I
  62. Ferrero,M.R., Heins,A.M., Soprano,L.L., Acosta,D.M., Esteva,M.I., Jacobs,T. and Duschak,V.G.
    Involvement of sulfates from cruzipain, a major antigen of Trypanosoma cruzi, in the interaction with immunomodulatory molecule Siglec-E
    Med Microbiol Immunol (2016) 205, 21-35. PubMed  Europe PubMed DOI
  63. Hoelz,L.V., Leal,V.F., Rodrigues,C.R., Pascutti,P.G., Albuquerque,M.G., Muri,E.M. and Dias,L.R.
    Molecular dynamics simulations of the free and inhibitor-bound cruzain systems in aqueous solvent: insights on the inhibition mechanism in acidic pH
    J Biomol Struct Dyn (2016) 34, 1969-1978. PubMed  Europe PubMed DOI
  64. Jefferson,T., McShan,D., Warfield,J. and Ogungbe,I.V.
    Screening and identification of inhibitors of Trypanosoma brucei cathepsin L with antitrypanosomal activity
    Chem Biol Drug Des (2016) 87, 154-158. PubMed  Europe PubMed DOI  I
  65. Latorre,A., Schirmeister,T., Kesselring,J., Jung,S., Johe,P., Hellmich,U.A., Heilos,A., Engels,B., Krauth-Siegel,R.L., Dirdjaja,N., Bou-Iserte,L., Rodriguez,S. and Gonzalez,F.V.
    Dipeptidyl nitroalkenes as potent reversible inhibitors of cysteine proteases rhodesain and cruzain
    ACS Med Chem Lett (2016) 7, 1073-1076. PubMed  Europe PubMed DOI  PMC  EPMC  I
  66. Sbaraglini,M.L., Bellera,C.L., Fraccaroli,L., Larocca,L., Carrillo,C., Talevi,A. and Alba Soto,C.D.
    Novel cruzipain inhibitors for the chemotherapy of chronic Chagas disease
    Int J Antimicrob Agents (2016) 48, 91-95. PubMed  Europe PubMed DOI  I
  67. Silva-Junior,E.F., Silva,E.P., Franca,P.H., Silva,J.P., Barreto,E.O., Silva,E.B., Ferreira,R.S., Gatto,C.C., Moreira,D.R., Siqueira-Neto,J.L., Mendonca-Junior,F.J., Lima,M.C., Bortoluzzi,J.H., Scotti,M.T., Scotti,L., Meneghetti,M.R., Aquino,T.M. and Araujo-Junior,J.X.
    Design, synthesis, molecular docking and biological evaluation of thiophen-2-iminothiazolidine derivatives for use against Trypanosoma cruzi
    Bioorg Med Chem (2016) 24, 4228-4240. PubMed  Europe PubMed DOI  I
    68. 2015
  68. Arafet,K., Ferrer,S. and Moliner,V.
    First quantum mechanics/molecular mechanics studies of the inhibition mechanism of cruzain by peptidyl halomethyl ketones
    Biochemistry (2015) 54, 3381-3391. PubMed  Europe PubMed DOI  I
  69. Avelar,L.A., Camilo,C.D., de Albuquerque,S., Fernandes,W.B., Goncalez,C., Kenny,P.W., Leitao,A., McKerrow,J.H., Montanari,C.A., Orozco,E.V., Ribeiro,J.F., Rocha,J.R., Rosini,F. and Saidel,M.E.
    Molecular design, synthesis and trypanocidal activity of dipeptidyl nitriles as cruzain inhibitors
    PLoS Negl Trop Dis (2015) 9, e0003916-e0003916. PubMed  Europe PubMed DOI  PMC  EPMC  I
  70. Branquinha,M.H., Oliveira,S.S., Sangenito,L.S., Sodre,C.L., Kneipp,L.F., D'Avila-Levy,C.M. and Santos,A.L.
    Cruzipain: an update on its potential as chemotherapy target against the human pathogen Trypanosoma cruzi
    Curr Med Chem (2015) 22, 2225-2235. PubMed  Europe PubMed  V
  71. de Almeida,L., Alves,K.F., Maciel-Rezende,C.M., Jesus Lde,O., Pires,F.R., Junior,C.V., Izidoro,M.A., Judice,W.A., Dos Santos,M.H. and Marques,M.J.
    Benzophenone derivatives as cysteine protease inhibitors and biological activity against Leishmania(L.) amazonensis amastigotes
    Biomed Pharmacother (2015) 75, 93-99. PubMed  Europe PubMed DOI  I
  72. Espindola,J.W., Cardoso,M.V., Filho,G.B., Oliveira E Silva,D.A., Moreira,D.R., Bastos,T.M., Simone,C.A., Soares,M.B., Villela,F.S., Ferreira,R.S., Castro,M.C., Pereira,V.R., Murta,S.M., Sales Junior,P.A., Romanha,A.J. and Leite,A.C.
    Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain
    Eur J Med Chem (2015) 101, 818-835. PubMed  Europe PubMed DOI  I
  73. Ferrao,P.M., D'Avila-Levy,C.M., Araujo-Jorge,T.C., Degrave,W.M., Goncalves,A.S., Garzoni,L.R., Lima,A.P., Feige,J.J., Bailly,S., Mendonca-Lima,L. and Waghabi,M.C.
    Cruzipain activates latent TGF-beta from host cells during T. cruzi invasion
    PLoS ONE (2015) 10, e0124832- PubMed  Europe PubMed DOI  PMC  EPMC  I
  74. Fonseca,N.C., da Cruz,L.F., da Silva Villela,F., do Nascimento Pereira,G.A., de Siqueira-Neto,J.L., Kellar,D., Suzuki,B.M., Ray,D., de Souza,T.B., Alves,R.J., Junior,P.A., Romanha,A.J., Murta,S.M., McKerrow,J.H., Caffrey,C.R., de Oliveira,R.B. and Ferreira,R.S.
    Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1
    Antimicrob Agents Chemother (2015) 59, 2666-2677. PubMed  Europe PubMed DOI  I
  75. Martinez-Mayorga,K., Byler,K.G., Ramirez-Hernandez,A.I. and Terrazas-Alvares,D.E.
    Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits
    Drug Discov Today (2015) 20, 890-898. PubMed  Europe PubMed DOI  I
  76. Neitz,R.J., Bryant,C., Chen,S., Gut,J., Hugo Caselli,E., Ponce,S., Chowdhury,S., Xu,H., Arkin,M.R., Ellman,J.A. and Renslo,A.R.
    Tetrafluorophenoxymethyl ketone cruzain inhibitors with improved pharmacokinetic properties as therapeutic leads for Chagas' disease
    Bioorg Med Chem Lett (2015) 25, 4834-4837. PubMed  Europe PubMed DOI  I
    77. 2014
  77. Batista,C.M., Medeiros,L.C., Eger,I. and Soares,M.J.
    mAb CZP-315.D9: an antirecombinant cruzipain monoclonal antibody that specifically labels the reservosomes of Trypanosoma cruzi epimastigotes
    Biomed Res Int (2014) 2014, 714749-714749. PubMed  Europe PubMed DOI  PMC  EPMC
  78. Ferreira,R.S., Dessoy,M.A., Pauli,I., Souza,M.L., Krogh,R., Sales,A.I., Oliva,G., Dias,L.C. and Andricopulo,A.D.
    Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents
    J Med Chem (2014) 57, 2380-2392. PubMed  Europe PubMed DOI  I
  79. Maeda,F.Y., Cortez,C., Izidoro,M.A., Juliano,L. and Yoshida,N.
    Fibronectin-degrading activity of Trypanosoma cruzi cysteine proteinase plays a role in host cell invasion
    Infect Immun (2014) 82, 5166-5174. PubMed  Europe PubMed DOI
  80. Miao,Q., Santamaria,C., Bailey,D., Genest,J., Ward,B.J. and Ndao,M.
    Apolipoprotein A-I truncations in Chagas disease are caused by cruzipain, the major cysteine protease of Trypanosoma cruzi
    Am J Pathol (2014) 184, 976-984. PubMed  Europe PubMed DOI
  81. Ndao,M., Beaulieu,C., Black,W.C., Isabel,E., Vasquez-Camargo,F., Nath-Chowdhury,M., Masse,F., Mellon,C., Methot,N. and Nicoll-Griffith,D.A.
    Reversible cysteine protease inhibitors show promise for a Chagas disease cure
    Antimicrob Agents Chemother (2014) 58, 1167-1178. PubMed  Europe PubMed DOI  I
  82. Rodrigues,A.C., Ortiz,P.A., Costa-Martins,A.G., Neves,L., Garcia,H.A., Alves,J.M., Camargo,E.P., Alfieri,S.C., Gibson,W. and Teixeira,M.M.
    Congopain genes diverged to become specific to Savannah, Forest and Kilifi subgroups of Trypanosoma congolense, and are valuable for diagnosis, genotyping and phylogenetic inferences
    Infect Genet Evol (2014) 23, 20-31. PubMed  Europe PubMed DOI
    83. 2013
  83. Assis,D.M., Gontijo,V.S., de Oliveira Pereira,I., Santos,J.A., Camps,I., Nagem,T.J., Ellena,J., Izidoro,M.A., Dos Santos Tersariol,I.L., de Barros,N.M., Doriguetto,A.C., Dos Santos,M.H. and Juliano,M.A.
    Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor
    J Enzyme Inhib Med Chem (2013) 28, 661-670. PubMed  Europe PubMed DOI  S  I
  84. Bellera,C.L., Balcazar,D.E., Alberca,L., Labriola,C.A., Talevi,A. and Carrillo,C.
    Application of computer-aided drug repurposing in the search of new cruzipain inhibitors: discovery of amiodarone and bromocriptine inhibitory effects
    J Chem Inf Model (2013) 53, 2402-2408. PubMed  Europe PubMed DOI  I
  85. Ponce,N.E., Carrera-Silva,E.A., Pellegrini,A.V., Cazorla,S.I., Malchiodi,E.L., Lima,A.P., Gea,S. and Aoki,M.P.
    Trypanosoma cruzi, the causative agent of Chagas disease, modulates interleukin-6-induced STAT3 phosphorylation via gp130 cleavage in different host cells
    Biochim Biophys Acta (2013) 1832, 485-494. PubMed  Europe PubMed DOI
  86. Wiggers,H.J., Rocha,J.R., Fernandes,W.B., Sesti-Costa,R., Carneiro,Z.A., Cheleski,J., Da Silva,A.B., Juliano,L., Cezari,M.H., Silva,J.S., McKerrow,J.H. and Montanari,C.A.
    Non-peptidic cruzain inhibitors with trypanocidal activity discovered by virtual screening and in vitro assay
    PLoS Negl Trop Dis (2013) 7, e2370-e2370. PubMed  Europe PubMed DOI  PMC  EPMC  I
    87. 2012
  87. Alvarez,V.E., Niemirowicz,G.T. and Cazzulo,J.J.
    The peptidases of Trypanosoma cruzi: digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death
    Biochim Biophys Acta (2012) 1824, 195-206. PubMed  Europe PubMed DOI  V
  88. Cazzulo,J.J.
    Cruzipain
    [ISSN:978-0-12-407743-0] (2012) 3, 1913-1918. DOI
  89. Lavrado,J., Mackey,Z., Hansell,E., McKerrow,J.H., Paulo,A. and Moreira,R.
    Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivatives
    Bioorg Med Chem Lett (2012) 22, 6256-6260. PubMed  Europe PubMed DOI  I
  90. Lee,G.M., Balouch,E., Goetz,D.H., Lazic,A., McKerrow,J.H. and Craik,C.S.
    Mapping inhibitor binding modes on an active cysteine protease via nuclear magnetic resonance spectroscopy
    Biochemistry (2012) 51, 10087-10098. PubMed  Europe PubMed DOI  E  S  I
  91. Lima,L., Ortiz,P.A., da Silva,F.M., Alves,J.M., Serrano,M.G., Cortez,A.P., Alfieri,S.C., Buck,G.A. and Teixeira,M.M.
    Repertoire, genealogy and genomic organization of cruzipain and homologous genes in Trypanosoma cruzi, T. cruzi-like and other trypanosome species
    PLoS ONE (2012) 7, e38385-e38385. PubMed  Europe PubMed DOI  PMC  EPMC
  92. Lozano,N.B., Maltarollo,V.G., Weber,K.C., Honorio,K.M., Guido,R.V., Andricopulo,A.D. and Da Silva,A.B.
    Molecular features for antitrypanosomal activity of thiosemicarbazones revealed by OPS-PLS QSAR studies
    Med Chem (2012) 8, 1045-1056. PubMed  Europe PubMed  I
  93. Mendez-Lucio,O., Romo-Mancillas,A., Medina-Franco,J.L. and Castillo,R.
    Computational study on the inhibition mechanism of cruzain by nitrile-containing molecules
    J Mol Graph Model (2012) 35, 28-35. PubMed  Europe PubMed DOI  I
  94. Rogers,K.E., Keranen,H., Durrant,J.D., Ratnam,J., Doak,A., Arkin,M.R. and McCammon,J.A.
    Novel cruzain inhibitors for the treatment of Chagas' disease
    Chem Biol Drug Des (2012) 80, 398-405. PubMed  Europe PubMed DOI  I
  95. Uehara,L.A., Moreira,O.C., Oliveira,A.C., Azambuja,P., Lima,A.P., Britto,C., Dos Santos,A.L., Branquinha,M.H. and D'Avila-Levy,C.M.
    Cruzipain promotes Trypanosoma cruzi adhesion to Rhodnius prolixus midgut
    PLoS Negl Trop Dis (2012) 6, e1958-e1958. PubMed  Europe PubMed DOI  PMC  EPMC
  96. Yang,P.Y., Wang,M., Li,L., Wu,H., He,C.Y. and Yao,S.Q.
    Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents
    Chemistry (2012) 18, 6528-6541. PubMed  Europe PubMed DOI  I
    97. 2011
  97. Acosta,D.M., Soprano,L.L., Ferrero,M., Landoni,M., Esteva,M.I., Couto,A.S. and Duschak,V.G.
    A striking common O-linked N-acetylglucosaminyl moiety between cruzipain and myosin
    Parasite Immunol (2011) 33, 363-370. PubMed  Europe PubMed DOI
  98. Boulange,A.F., Khamadi,S.A., Pillay,D., Coetzer,T.H. and Authie,E.
    Production of congopain, the major cysteine protease of Trypanosoma (Nannomonas) congolense, in Pichia pastoris reveals unexpected dimerisation at physiological pH
    Protein Expr Purif (2011) 75, 95-103. PubMed  Europe PubMed DOI  E
  99. Caffrey,C.R., Lima,A.P. and Steverding,D.
    Cysteine peptidases of kinetoplastid parasites
    Adv Exp Med Biol (2011) 712, 84-99. PubMed  Europe PubMed DOI  V
  100. Caputto,M.E., Fabian,L.E., Benitez,D., Merlino,A., Rios,N., Cerecetto,H., Moltrasio,G.Y., Moglioni,A.G., Gonzalez,M. and Finkielsztein,L.M.
    Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents
    Bioorg Med Chem (2011) 19, 6818-6826. PubMed  Europe PubMed DOI  I
  101. Doyle,P.S., Zhou,Y.M., Hsieh,I., Greenbaum,D.C., McKerrow,J.H. and Engel,J.C.
    The Trypanosoma cruzi protease cruzain mediates immune evasion
    PLoS Pathog (2011) 7, e1002139-e1002139. PubMed  Europe PubMed DOI  PMC  EPMC
  102. Sajid,M., Robertson,S.A., Brinen,L.S. and McKerrow,J.H.
    Cruzain : the path from target validation to the clinic
    Adv Exp Med Biol (2011) 712, 100-115. PubMed  Europe PubMed DOI  V
    103. 2010
  103. Beaulieu,C., Isabel,E., Fortier,A., Masse,F., Mellon,C., Methot,N., Ndao,M., Nicoll-Griffith,D., Lee,D., Park,H. and Black,W.C.
    Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease
    Bioorg Med Chem Lett (2010) 20, 7444-7449. PubMed  Europe PubMed DOI  I
  104. Benitez-Hernandez,I., Mendez-Enriquez,E., Ostoa,P., Fortoul,T., Ramirez,J.A., Stempin,C., Cerban,F., Soldevila,G. and Garcia-Zepeda,E.A.
    Proteolytic cleavage of chemokines by Trypanosoma cruzi's cruzipain inhibits chemokine functions by promoting the generation of antagonists
    Immunobiology (2010) 215, 413-426. PubMed  Europe PubMed DOI
  105. Brak,K., Kerr,I.D., Barrett,K.T., Fuchi,N., Debnath,M., Ang,K., Engel,J.C., McKerrow,J.H., Doyle,P.S., Brinen,L.S. and Ellman,J.A.
    Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy
    J Med Chem (2010) 53, 1763-1773. PubMed  Europe PubMed DOI  I
  106. Cazorla,S.I., Frank,F.M., Becker,P.D., Arnaiz,M., Mirkin,G.A., Corral,R.S., Guzman,C.A. and Malchiodi,E.L.
    Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection
    J Infect Dis (2010) 202, 136-144. PubMed  Europe PubMed DOI
  107. Durrant,J.D., Keranen,H., Wilson,B.A. and McCammon,J.A.
    Computational identification of uncharacterized cruzain binding sites
    PLoS Negl Trop Dis (2010) 4, e676-e676. PubMed  Europe PubMed DOI  PMC  EPMC
  108. Ferreira,R.S., Simeonov,A., Jadhav,A., Eidam,O., Mott,B.T., Keiser,M.J., McKerrow,J.H., Maloney,D.J., Irwin,J.J. and Shoichet,B.K.
    Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors
    J Med Chem (2010) 53, 4891-4905. PubMed  Europe PubMed DOI  I
  109. Luci,D., Lea,W., Ferreira,R., Shoichet,B., Simeonov,A., Rodriguez,A., Jadhav,A. and Maloney,D.J.
    Reversible and non-covalent benzimidazole-based in vivo lead for Chagas disease
    [ISSN:NBK133417] (2010) PubMed  Europe PubMed  I
  110. Mott,B.T., Ferreira,R.S., Simeonov,A., Jadhav,A., Ang,K.K., Leister,W., Shen,M., Silveira,J.T., Doyle,P.S., Arkin,M.R., McKerrow,J.H., Inglese,J., Austin,C.P., Thomas,C.J., Shoichet,B.K. and Maloney,D.J.
    Identification and optimization of inhibitors of trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB
    J Med Chem (2010) 53, 52-60. PubMed  Europe PubMed DOI  S  I
  111. Pillay,D., Boulange,A.F. and Coetzer,T.H.
    Expression, purification and characterisation of two variant cysteine peptidases from Trypanosoma congolense with active site substitutions
    Protein Expr Purif (2010) 74, 264-271. PubMed  Europe PubMed DOI
  112. Rodrigues,G.C., Aguiar,A.P., da Silva Goncalves Vianez Jr., Macrae,A., De Melo,A.C.N. and Vermelho,A.B.
    Peptidase inhibitors as a possible therapeutic strategy for Chagas disease
    Curr Enzyme Inhib (2010) 6, 183-194. DOI  I
    113. 2009
  113. Bryant,C., Kerr,I.D., Debnath,M., Ang,K.K., Ratnam,J., Ferreira,R.S., Jaishankar,P., Zhao,D., Arkin,M.R., McKerrow,J.H., Brinen,L.S. and Renslo,A.R.
    Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases
    Bioorg Med Chem Lett (2009) 19, 6218-6221. PubMed  Europe PubMed DOI  S  I
  114. Caffrey,C.R. and Steverding,D.
    Kinetoplastid papain-like cysteine peptidases
    Mol Biochem Parasitol (2009) 167, 12-19. PubMed  Europe PubMed DOI  I
  115. dos Santos Filho,J.M., Leite,A.C., de Oliveira,B.G., Moreira,D.R., Lima,M.S., Soares,M.B. and Leite,L.F.
    Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents
    Bioorg Med Chem (2009) 17, 6682-6691. PubMed  Europe PubMed DOI  I
  116. Duschak,V.G. and Couto,A.S.
    Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review
    Curr Med Chem (2009) 16, 3174-3202. PubMed  Europe PubMed DOI  V
  117. Ferreira,R.S., Bryant,C., Ang,K.K., McKerrow,J.H., Shoichet,B.K. and Renslo,A.R.
    Divergent modes of enzyme inhibition in a homologous structure-activity series
    J Med Chem (2009) 52, 5005-5008. PubMed  Europe PubMed DOI  I
  118. Huson,L.E., Authie,E., Boulange,A.F., Goldring,J.P. and Coetzer,T.H.
    Modulation of the immunogenicity of the Trypanosoma congolense cysteine protease, congopain, through complexation with alpha(2)-macroglobulin
    Vet Res (2009) 40, 52-52. PubMed  Europe PubMed DOI  PMC  EPMC
  119. Kerr,I.D., Lee,J.H., Farady,C.J., Marion,R., Rickert,M., Sajid,M., Pandey,K.C., Caffrey,C.R., Legac,J., Hansell,E., McKerrow,J.H., Craik,C.S., Rosenthal,P.J. and Brinen,L.S.
    Vinyl sulfones as antiparasitic agents and a structural basis for drug design
    J Biol Chem (2009) 284, 25697-25703. PubMed  Europe PubMed DOI  PMC  EPMC  S  I
  120. Romeiro,N.C., Aguirre,G., Hernandez,P., Gonzalez,M., Cerecetto,H., Aldana,I., Perez-Silanes,S., Monge,A., Barreiro,E.J. and Lima,L.M.
    Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates
    Bioorg Med Chem (2009) 17, 641-652. PubMed  Europe PubMed DOI  I
    121. 2008
  121. Acosta,D.M., Arnaiz,M.R., Esteva,M.I., Barboza,M., Stivale,D., Orlando,U.D., Torres,S., Laucella,S.A., Couto,A.S. and Duschak,V.G.
    Sulfates are main targets of immune responses to cruzipain and are involved in heart damage in BALB/c immunized mice
    Int Immunol (2008) 20, 461-470. PubMed  Europe PubMed DOI
  122. Brak,K., Doyle,P.S., McKerrow,J.H. and Ellman,J.A.
    Identification of a new class of nonpeptidic inhibitors of cruzain
    J Am Chem Soc (2008) 130, 6404-6410. PubMed  Europe PubMed DOI  PMC  EPMC  I
  123. Cazorla,S.I., Frank,F.M., Becker,P.D., Corral,R.S., Guzman,C.A. and Malchiodi,E.L.
    Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model
    Vaccine (2008) 26, 1999-2009. PubMed  Europe PubMed DOI
  124. Chen,Y.T., Lira,R., Hansell,E., McKerrow,J.H. and Roush,W.R.
    Synthesis of macrocyclic trypanosomal cysteine protease inhibitors
    Bioorg Med Chem Lett (2008) 18, 5860-5863. PubMed  Europe PubMed DOI  PMC  EPMC  I
  125. Frank,F.M., Cazorla,S.I., Sartori,M.J. and Corral,R.S.
    Elicitation of specific, Th1-biased immune response precludes skeletal muscle damage in cruzipain-vaccinated mice
    Exp Mol Pathol (2008) 84, 64-70. PubMed  Europe PubMed DOI
  126. Freitas,R.F., Oprea,T.I. and Montanari,C.A.
    2D QSAR and similarity studies on cruzain inhibitors aimed at improving selectivity over cathepsin L
    Bioorg Med Chem (2008) 16, 838-853. PubMed  Europe PubMed DOI  I
  127. Guido,R.V., Trossini,G.H., Castilho,M.S., Oliva,G., Ferreira,E.I. and Andricopulo,A.D.
    Structure-activity relationships for a class of selective inhibitors of the major cysteine protease from Trypanosoma cruzi
    J Enzyme Inhib Med Chem (2008) 23, 964-973. PubMed  Europe PubMed DOI  I
  128. Jaishankar,P., Hansell,E., Zhao,D.M., Doyle,P.S., McKerrow,J.H. and Renslo,A.R.
    Potency and selectivity of P2/P3-modified inhibitors of cysteine proteases from trypanosomes
    Bioorg Med Chem Lett (2008) 18, 624-628. PubMed  Europe PubMed DOI  I
  129. Scharfstein,J. and Lima,A.P.
    Roles of naturally occurring protease inhibitors in the modulation of host cell signaling and cellular invasion by Trypanosoma cruzi
    Subcell Biochem (2008) 47, 140-154. PubMed  Europe PubMed DOI
  130. Zanatta,N., Amaral,S.S., Dos Santos,J.M., de Mello,D.L., Fernandes,L., Bonacorso,H.G., Martins,M.A., Andricopulo,A.D. and Borchhardt,D.M.
    Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines
    Bioorg Med Chem (2008) 16, 10236-10243. PubMed  Europe PubMed DOI  I
    131. 2007
  131. Doyle,P.S., Zhou,Y.M., Engel,J.C. and McKerrow,J.H.
    A cysteine protease inhibitor cures Chagas' disease in an immunodeficient-mouse model of infection
    Antimicrob Agents Chemother (2007) 51, 3932-3939. PubMed  Europe PubMed DOI  PMC  EPMC  I
  132. Gonzalez,F.V., Izquierdo,J., Rodriguez,S., McKerrow,J.H. and Hansell,E.
    Dipeptidyl-alpha,beta-epoxyesters as potent irreversible inhibitors of the cysteine proteases cruzain and rhodesain
    Bioorg Med Chem Lett (2007) 17, 6697-6700. PubMed  Europe PubMed DOI  I
  133. Leite,A.C., Moreira,D.R., Cardoso,M.V., Hernandes,M.Z., Alves Pereira,V.R., Silva,R.O., Kiperstok,A.C., Lima,M. and Soares,M.B.
    Synthesis, cruzain docking, and in vitro studies of aryl-4-oxothiazolylhydrazones against Trypanosoma cruzi
    ChemMedChem (2007) 2, 1339-1345. PubMed  Europe PubMed DOI  I
  134. Reis,F.C., Costa,T.F., Sulea,T., Mezzetti,A., Scharfstein,J., Bromme,D., Menard,R. and Lima,A.P.
    The propeptide of cruzipain - a potent selective inhibitor of the trypanosomal enzymes cruzipain and brucipain, and of the human enzyme cathepsin F
    FEBS J (2007) 274, 1224-1234. PubMed  Europe PubMed DOI
    135. 2006
  135. [YEAR:6-3-2006]Choe,Y., Leonetti,F., Greenbaum,D.C., Lecaille,F., Bogyo,M., Bromme,D., Ellman,J.A. and Craik,C.S.
    Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities
    J Biol Chem (6-3-2006) 281, 12824-12832. PubMed  Europe PubMed DOI  P
  136. Gea,S., Guinazu,N., Pellegrini,A., Carrera Silva,E.A., Giordanengo,L., Cano,R. and Aoki,M.P.
    Cruzipain, a major Trypanosoma cruzi cystein protease in the host-parasite interplay
    Inmunologia (2006) 25, 225-238.  V
    137. 2005
  137. Barboza,M., Duschak,V.G., Fukuyama,Y., Nonami,H., Erra-Balsells,R., Cazzulo,J.J. and Couto,A.S.
    Structural analysis of the N-glycans of the major cysteine proteinase of Trypanosoma cruzi. Identification of sulfated high-mannose type oligosaccharides
    FEBS J (2005) 272, 3803-3815. PubMed  Europe PubMed DOI
  138. Barr,S.C., Warner,K.L., Kornreic,B.G., Piscitelli,J., Wolfe,A., Benet,L. and McKerrow,J.H.
    A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi
    Antimicrob Agents Chemother (2005) 49, 5160-5161. PubMed  Europe PubMed DOI  PMC  EPMC  I
  139. [YEAR:15-3-2005]Choe,Y., Brinen,L.S., Price,M.S., Engel,J.C., Lange,M., Grisostomi,C., Weston,S.G., Pallai,P.V., Cheng,H., Hardy,L.W., Hartsough,D.S., McMakin,M., Tilton,R.F., Baldino,C.M. and Craik,C.S.
    Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease
    Bioorg Med Chem (15-3-2005) 13, 2141-2156. PubMed  Europe PubMed DOI  S  I
  140. [YEAR:3-1-2005]Fujii,N., Mallari,J.P., Hansell,E.J., Mackey,Z., Doyle,P., Zhou,Y.M., Gut,J., Rosenthal,P.J., McKerrow,J.H. and Guy,R.K.
    Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain
    Bioorg Med Chem Lett (3-1-2005) 15, 121-123. PubMed  Europe PubMed DOI  I
  141. [YEAR:9-8-2005]Godat,E., Chowdhury,S., Lecaille,F., Belghazi,M., Purisima,E.O. and Lalmanach,G.
    Inhibition of a cathepsin L-like cysteine protease by a chimeric propeptide-derived inhibitor
    Biochemistry (9-8-2005) 44, 10486-10493. PubMed  Europe PubMed DOI
  142. [YEAR:1-3-2005]Polticelli,F., Zaini,G., Bolli,A., Antonini,G., Gradoni,L. and Ascenzi,P.
    Probing the cruzain S2 recognition subsite: a kinetic and binding energy calculation study
    Biochemistry (1-3-2005) 44, 2781-2789. PubMed  Europe PubMed DOI
    143. 2004
  143. Aparicio,I.M., Scharfstein,J. and Lima,A.P.
    A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes
    Infect Immun (2004) 72, 5892-5902. PubMed  Europe PubMed DOI  PMC  EPMC
  144. [YEAR:12-3-2004]Bocedi,A., Gradoni,L., Menegatti,E. and Ascenzi,P.
    Kinetics of parasite cysteine proteinase inactivation by NO-donors
    Biochem Biophys Res Commun (12-3-2004) 315, 710-718. PubMed  Europe PubMed DOI
  145. Cazzulo,J.J.
    Cruzipain
    [ISSN:0-12-079610-4] (2004) 2, 1160-1163.  V
  146. Judice,W.A., Puzer,L., Cotrin,S.S., Carmona,A.K., Coombs,G.H., Juliano,L. and Juliano,M.A.
    Carboxydipeptidase activities of recombinant cysteine peptidases. Cruzain of Trypanosoma cruzi and CPB of Leishmania mexicana
    Eur J Biochem (2004) 271, 1046-1053. PubMed  Europe PubMed DOI  P
  147. Rossi,A., Deveraux,Q., Turk,B. and Sali,A.
    Comprehensive search for cysteine cathepsins in the human genome
    Biol Chem (2004) 385, 363-372. PubMed  Europe PubMed DOI
    148. 2003
  148. [YEAR:11-8-2003]Berasain,P., Carmona,C., Frangione,B., Cazzulo,J.J. and Goni,F.
    Specific cleavage sites on human IgG subclasses by cruzipain, the major cysteine proteinase from Trypanosoma cruzi
    Mol Biochem Parasitol (11-8-2003) 130, 23-29. PubMed  Europe PubMed DOI
  149. Chibale,K. and Musonda,C.C.
    The synthesis of parasitic cysteine protease and trypanothione reductase inhibitors
    Curr Med Chem (2003) 10, 1863-1889. PubMed  Europe PubMed DOI  I
  150. [YEAR:20-10-2003]Chiyanzu,I., Hansell,E., Gut,J., Rosenthal,P.J., McKerrow,J.H. and Chibale,K.
    Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain
    Bioorg Med Chem Lett (20-10-2003) 13, 3527-3530. PubMed  Europe PubMed DOI  I
  151. Huang,L., Brinen,L.S. and Ellman,J.A.
    Crystal structures of reversible ketone-based inhibitors of the cysteine protease cruzain
    Bioorg Med Chem (2003) 11, 21-29. PubMed  Europe PubMed DOI  S  I
    152. 2002
  152. Alvarez,V., Parussini,F., Aslund,L. and Cazzulo,J.J.
    Expression in insect cells of active mature cruzipain from Trypanosoma cruzi, containing its C-terminal domain
    Protein Expr Purif (2002) 26, 467-475. PubMed  Europe PubMed DOI  E
  153. [YEAR:20-6-2002]Du,X., Guo,C., Hansell,E., Doyle,P.S., Caffrey,C.R., Holler,T.P., McKerrow,J.H. and Cohen,F.E.
    Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain
    J Med Chem (20-6-2002) 45, 2695-2707. PubMed  Europe PubMed DOI  I
  154. [YEAR:21-10-2002]Huang,L. and Ellman,J.A.
    General solid-phase method to prepare novel cyclic ketone inhibitors of the cysteine protease cruzain
    Bioorg Med Chem Lett (21-10-2002) 12, 2993-2996. PubMed  Europe PubMed DOI  I
  155. [YEAR:31-1-2002]Huang,L., Lee,A. and Ellman,J.A.
    Identification of potent and selective mechanism-based inhibitors of the cysteine protease cruzain using solid-phase parallel synthesis
    J Med Chem (31-1-2002) 45, 676-684. PubMed  Europe PubMed DOI  I
  156. Lalmanach,G., Boulange,A., Serveau,C., Lecaille,F., Scharfstein,J., Gauthier,F. and Authie,E.
    Congopain from Trypanosoma congolense: drug target and vaccine candidate
    Biol Chem (2002) 383, 739-749. PubMed  Europe PubMed DOI
  157. [YEAR:22-2-2002]Lima,A.P., Almeida,P.C., Tersariol,I.L., Schmitz,V., Schmaier,A.H., Juliano,L., Hirata,I.Y., Muller-Esterl,W., Chagas,J.R. and Scharfstein,J.
    Heparan sulfate modulates kinin release by Trypanosoma cruzi through the activity of cruzipain
    J Biol Chem (22-2-2002) 277, 5875-5881. PubMed  Europe PubMed DOI
  158. [YEAR:3-6-2002]Rodrigues,C.R., Flaherty,T.M., Springer,C., McKerrow,J.H. and Cohen,F.E.
    CoMFA and HQSAR of acylhydrazide cruzain inhibitors
    Bioorg Med Chem Lett (3-6-2002) 12, 1537-1541. PubMed  Europe PubMed DOI  I
    159. 2001
  159. Alves,L.C., Melo,R.L., Cezari,M.H., Sanderson,S.J., Mottram,J.C., Coombs,G.H., Juliano,L. and Juliano,M.A.
    Analysis of the S(2) subsite specificities of the recombinant cysteine proteinases CPB of Leishmania mexicana, and cruzain of Trypanosoma cruzi, using fluorescent substrates containing non-natural basic amino acids
    Mol Biochem Parasitol (2001) 117, 137-143. PubMed  Europe PubMed DOI  P
  160. Cazzulo,J.J., Stoka,V. and Turk,V.
    The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease
    Curr Pharm Des (2001) 7, 1143-1156. PubMed  Europe PubMed DOI
  161. de Oliveira,C., Santana,L.A., Carmona,A.K., Cezari,M.H., Sampaio,M.U., Sampaio,C.A.M. and Oliva,M.L.V.
    Structure of cruzipain/cruzain inhibitors isolated from Bauhinia bauhinioides seeds
    Biol Chem (2001) 382, 847-852. PubMed  Europe PubMed DOI
  162. Judice,W.A.S., Cezari,M.H.S., Lima,A.P.C.A., Scharfstein,J., Chagas,J.R., Tersariol,I.L.S., Juliano,M.A. and Juliano,L.
    Comparison of the specificity, stability and individual rate constants with respective activation parameters for the peptidase activity of cruzipain and its recombinant form, cruzain, from Trypanosoma cruzi
    Eur J Biochem (2001) 268, 6578-6586. PubMed  Europe PubMed DOI
  163. Lecaille,F., Authie,E., Moreau,T., Serveau,C., Gauthier,F. and Lalmanach,G.
    Subsite specificity of trypanosomal cathepsin L-like cysteine proteases. Probing the S2 pocket with phenylalanine-derived amino acids
    Eur J Biochem (2001) 268, 2733-2741. PubMed  Europe PubMed DOI
  164. [YEAR:2-11-2001]Lecaille,F., Cotton,J., McKerrow,J.H., Ferrer-Di Martino,M., Boll-Bataille,E., Gauthier,F. and Lalmanach,G.
    Reversible inhibition of cathepsin L-like proteases by 4-mer pseudopeptides
    FEBS Lett (2-11-2001) 507, 362-366. PubMed  Europe PubMed DOI
  165. [YEAR:25-4-2001]Lima,A.P., dos Reis,F.C., Serveau,C., Lalmanach,G., Juliano,L., Menard,R., Vernet,T., Thomas,D.Y., Storer,A.C. and Scharfstein,J.
    Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors
    Mol Biochem Parasitol (25-4-2001) 114, 41-52. PubMed  Europe PubMed DOI  I
  166. Monteiro,A.C., Abrahamson,M., Lima,A.P., Vannier-Santos,M.A. and Scharfstein,J.
    Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi
    J Cell Sci (2001) 114, 3933-3942. PubMed  Europe PubMed
  167. [YEAR:22-10-2001]Roush,W.R., Cheng,J., Knapp-Reed,B., Alvarez-Hernandez,A., McKerrow,J.H., Hansell,E. and Engel,J.C.
    Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain
    Bioorg Med Chem Lett (22-10-2001) 11, 2759-2762. PubMed  Europe PubMed DOI  I
  168. Salvati,L., Mattu,M., Polticelli,F., Tiberi,F., Gradoni,L., Venturini,G., Bolognesi,M. and Ascenzi,P.
    Modulation of the catalytic activity of cruzipain, the major cysteine proteinase from Trypanosoma cruzi, by temperature and pH
    Eur J Biochem (2001) 268, 3253-3258. PubMed  Europe PubMed DOI
    169. 2000
  169. [YEAR:15-8-2000]Brinen,L.S., Hansell,E., Cheng,J., Roush,W.R., McKerrow,J.H. and Fletterick,R.J.
    A target within the target: probing cruzain's P1' site to define structural determinants for the Chagas' disease protease
    Structure (15-8-2000) 8, 831-840. PubMed  Europe PubMed DOI
  170. [YEAR:5-7-2000]Harris,J.L., Backes,B.J., Leonetti,F., Mahrus,S., Ellman,J.A. and Craik,C.S.
    Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries
    Proc Natl Acad Sci U S A (5-7-2000) 97, 7754-7759. PubMed  Europe PubMed DOI  PMC  EPMC  P
  171. Jacobsen,W., Christians,U. and Benet,L.Z.
    In vitro evaluation of the disposition of a novel cysteine protease inhibitor
    Drug Metab Dispos (2000) 28, 1343-1351. PubMed  Europe PubMed  I
  172. [YEAR:8-12-2000]Roush,W.R., Hernandez,A.A., McKerrow,J.H., Selzer,P.M., Hansell,E. and Engel,J.C.
    Design, synthesis and evaluation of D-homophenylalanyl epoxysuccinate inhibitors of the trypanosomal cysteine protease cruzain
    Tetrahedron (8-12-2000) 56, 9747-9762.  I
  173. [YEAR:3-3-2000]Stoka,V., Turk,B., McKerrow,J.H., Bjork,I., Cazzulo,J.J. and Turk,V.
    The high stability of cruzipain against pH-induced inactivation is not dependent on its C-terminal domain
    FEBS Lett (3-3-2000) 469, 29-32. PubMed  Europe PubMed DOI
  174. Yong,V., Schmitz,V., Vannier-Santos,M.A., de Lima,A.P., Lalmanach,G., Juliano,L., Gauthier,F. and Scharfstein,J.
    Altered expression of cruzipain and a cathepsin B-like target in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases
    Mol Biochem Parasitol (2000) 109, 47-59. PubMed  Europe PubMed DOI
    175. 1999
  175. Serveau,C., Lalmanach,G., Hirata,I., Scharfstein,J., Juliano,M.A. and Gauthier,F.
    Discrimination of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, and mammalian cathepsins B and L, by a pH-inducible fluorogenic substrate of trypanosomal cysteine proteinases
    Eur J Biochem (1999) 259, 275-280. PubMed  Europe PubMed DOI
    176. 1998
  176. [YEAR:17-8-1998]Engel,J.C., Doyle,P.S., Hsieh,I. and McKerrow,J.H.
    Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection
    J Exp Med (17-8-1998) 188, 725-734. PubMed  Europe PubMed DOI  PMC  EPMC  I
  177. [YEAR:25-9-1998]Lalmanach,G., Lecaille,F., Chagas,J.R., Authie,E., Scharfstein,J., Juliano,M.A. and Gauthier,F.
    Inhibition of trypanosomal cysteine proteinases by their propeptides
    J Biol Chem (25-9-1998) 273, 25112-25116. PubMed  Europe PubMed DOI
  178. [YEAR:6-10-1998]Roush,W.R., Gonzalez,F.V., McKerrow,J.H. and Hansell,E.
    Design and synthesis of dipeptidyl alpha',beta'-epoxy ketones, potent irreversible inhibitors of the cysteine protease cruzain
    Bioorg Med Chem Lett (6-10-1998) 8, 2809-2812. PubMed  Europe PubMed DOI  I
  179. Scheidt,K.A., Roush,W.R., McKerrow,J.H., Selzer,P.M., Hansell,E. and Rosenthal,P.J.
    Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors
    Bioorg Med Chem (1998) 6, 2477-2494. PubMed  Europe PubMed DOI  I
    180. 1997
  180. Bevec,T., Stoka,V., Pungercic,G., Cazzulo,J.J. and Turk,V.
    A fragment of the major histocompatibility complex class II-associated p41 invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi
    FEBS Lett (1997) 401, 259-261. PubMed  Europe PubMed DOI
  181. Cazzulo,J.J., Stoka,V. and Turk,V.
    Cruzipain, the major cysteine proteinase from the protozoan parasite Trypanosoma cruzi
    Biol Chem (1997) 378, 1-10. PubMed  Europe PubMed
  182. Del Nery,E., Juliano,M.A., Lima,A.P., Scharfstein,J. and Juliano,L.
    Kininogenase activity by the major cysteinyl proteinase (cruzipain) from Trypanosoma cruzi
    J Biol Chem (1997) 272, 25713-25718. PubMed  Europe PubMed DOI
  183. Del Nery,E., Juliano,M.A., Meldal,M., Svendsen,I., Scharfstein,J., Walmsley,A. and Juliano,L.
    Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides
    Biochem J (1997) 323, 427-433. PubMed  Europe PubMed  PMC  EPMC
  184. Gillmor,S.A., Craik,C.S. and Fletterick,R.J.
    Structural determinants of specificity in the cysteine protease cruzain
    Protein Sci (1997) 6, 1603-1611. PubMed  Europe PubMed DOI  PMC  EPMC  S  I
  185. Tomas,A.M., Miles,M.A. and Kelly,J.M.
    Overexpression of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, is associated with enhanced metacyclogenesis
    Eur J Biochem (1997) 244, 596-603. PubMed  Europe PubMed
    186. 1996
  186. Cazzulo,J.J., Bravo,M., Raimondi,A., Engstrom,U., Lindeberg,G. and Hellman,U.
    Hydrolysis of synthetic peptides by cruzipain, the major cysteine proteinase from Trypanosoma cruzi, provides evidence for self-processing and the possibility of more specific substrates for the enzyme
    Cell Mol Biol (Noisy-le-grand) (1996) 42, 691-696. PubMed  Europe PubMed
  187. Metzner,S.I., Sousa,M.C., Hellman,U., Cazzulo,J.J. and Parodi,A.J.
    The use of UDP-Glc:glycoprotein glucosyltransferase for radiolabeling protein-linked high mannose-type oligosaccharides
    Cell Mol Biol (Noisy-le-grand) (1996) 42, 631-635. PubMed  Europe PubMed
  188. Serveau,C., Lalmanach,G., Juliano,M.A., Scharfstein,J., Juliano,L. and Gauthier,F.
    Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors
    Biochem J (1996) 313, 951-956. PubMed  Europe PubMed  PMC  EPMC
    189. 1995
  189. Fish,W.R., Nkhungulu,Z.M., Muriuki,C.W., Ndegwa,D.M., Lonsdale-Eccles,J.D. and Steyaert,J.
    Primary structure and partial characterization of a life-cycle-regulated cysteine protease from Trypanosoma (Nannomonas) congolense
    Gene (1995) 161, 125-128. PubMed  Europe PubMed DOI
  190. McGrath,M.E., Eakin,A.E., Engel,J.C., McKerrow,J.H., Craik,C.S. and Fletterick,R.J.
    The crystal structure of cruzain: A therapeutic target for Chagas' disease
    J Mol Biol (1995) 247, 251-259. PubMed  Europe PubMed DOI  S
  191. McKerrow,J.H., McGrath,M.E. and Engel,J.C.
    The cysteine protease of Trypanosoma cruzi as a model for antiparasite drug design
    Parasitol Today (1995) 11, 279-282. PubMed  Europe PubMed
    192. 1994
  192. [YEAR:15-11-1994]Franke de Cazzulo,B.M., Martinez,J., North,M.J., Coombs,G.H. and Cazzulo,J.J.
    Effects of proteinase inhibitors on the growth and differentiation of Trypanosoma cruzi
    FEMS Microbiol Lett (15-11-1994) 124, 81-86. PubMed  Europe PubMed DOI  I
  193. Lima,A.P., Tessier,D.C., Thomas,D.Y., Scharfstein,J., Storer,A.C. and Vernet,T.
    Identification of new cysteine protease gene isoforms in Trypanosoma cruzi
    Mol Biochem Parasitol (1994) 67, 333-338. PubMed  Europe PubMed DOI
  194. North,M.J.
    Cysteine endopeptidases of parasitic protozoa
    Methods Enzymol (1994) 244, 523-539. PubMed  Europe PubMed DOI  V
  195. Yokoyama-Yasunaka,J.K., Pral,E.M., Oliveira Junior,O.C., Alfieri,S.C. and Stolf,A.M.
    Trypanosoma cruzi: identification of proteinases in shed components of trypomastigote forms
    Acta Trop (1994) 57, 307-315. PubMed  Europe PubMed DOI
    196. 1993
  196. Eakin,A.E., McGrath,M.E., McKerrow,J.H., Fletterick,R.J. and Craik,C.S.
    Production of crystallizable cruzain, the major cysteine protease from Trypanosoma cruzi
    J Biol Chem (1993) 268, 6115-6118. PubMed  Europe PubMed
  197. Labriola,C., Sousa,M. and Cazzulo,J.J.
    Purification of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi by affinity chromatography
    Biol Res (1993) 26, 101-107. PubMed  Europe PubMed
  198. Martinez,J., Campetella,O., Frasch,A.C. and Cazzulo,J.J.
    The reactivity of sera from chagasic patients against different fragments of cruzipain, the major cysteine proteinase from Trypanosoma cruzi, suggests the presence of defined antigenic and catalytic domains
    Immunol Lett (1993) 35, 191-196. PubMed  Europe PubMed DOI
    199. 1992
  199. Campetella,O., Henriksson,J., Aslund,L., Frasch,A.C., Pettersson,U. and Cazzulo,J.J.
    The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is encoded by multiple polymorphic tandemly organized genes located on different chromosomes
    Mol Biochem Parasitol (1992) 50, 225-234. PubMed  Europe PubMed DOI
  200. Cazzulo,J.J., Martinez,J., Parodi,A.J., Wernstedt,C. and Hellman,U.
    On the post-translational modifications at the C-terminal domain of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi
    FEMS Microbiol Lett (1992) 100, 411-416. PubMed  Europe PubMed
  201. Cazzulo,J.J. and Frasch,A.C.
    SAPA/trans-sialidase and cruzipain: two antigens from Trypanosoma cruzi contain immunodominant but enzymatically inactive domains
    FASEB J (1992) 6, 3259-3264. PubMed  Europe PubMed
  202. Eakin,A.E., Mills,A.A., Harth,G., McKerrow,J.H. and Craik,C.S.
    The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi
    J Biol Chem (1992) 267, 7411-7420. PubMed  Europe PubMed
  203. [YEAR:15-8-1992]Martinez,J. and Cazzulo,J.J.
    Anomalous electrophoretic behaviour of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi in relation to its apparent molecular mass
    FEMS Microbiol Lett (15-8-1992) 74, 225-229. PubMed  Europe PubMed
    204. 1991
  204. Aslund,L., Henriksson,J., Campetella,O., Frasch,A.C., Pettersson,U. and Cazzulo,J.J.
    The C-terminal extension of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi
    Mol Biochem Parasitol (1991) 45, 345-347. PubMed  Europe PubMed DOI
  205. McKerrow,J.H.
    New insights into the structure of a Trypanosoma cruzi protease
    Parasitol Today (1991) 7, 132-133. PubMed  Europe PubMed DOI
  206. Raimondi,A., Wernstedt,C., Hellman,U. and Cazzulo,J.J.
    Degradation of oxidised insulin A and B chains by the major cysteine proteinase (cruzipain) from Trypanosoma cruzi epimastigotes
    Mol Biochem Parasitol (1991) 49, 341-344. PubMed  Europe PubMed DOI  P
    207. 1990
  207. Bontempi,E. and Cazzulo,J.J.
    Digestion of human immunoglobulin G by the major cysteine proteinase (cruzipain) from Trypanosoma cruzi
    FEMS Microbiol Lett (1990) 58, 337-341. PubMed  Europe PubMed
  208. Cazzulo,J.J., Cazzulo Franke,M.C., Martinez,J. and Franke de Cazzulo,B.M.
    Some kinetic properties of a cysteine proteinase (cruzipain) from Trypanosoma cruzi
    Biochim Biophys Acta (1990) 1037, 186-191. PubMed  Europe PubMed DOI
  209. Greig,S. and Ashall,F.
    Electrophoretic detection of Trypanosoma cruzi peptidases
    Mol Biochem Parasitol (1990) 39, 31-37. PubMed  Europe PubMed DOI
  210. Murta,A.C., Persechini,P.M., Padron,T., de Souza,W., Guimaraes,J.A. and Scharfstein,J.
    Structural and functional identification of GP57/51 antigen of Trypanosoma cruzi as a cysteine proteinase
    Mol Biochem Parasitol (1990) 43, 27-38. PubMed  Europe PubMed
  211. Souto-Padron,T., Campetella,O.E., Cazzulo,J.J. and de Souza,W.
    Cysteine proteinase in Trypanosoma cruzi: immunocytochemical localization and involvement in parasite-host cell interaction
    J Cell Sci (1990) 96, 485-490. PubMed  Europe PubMed
    212. 1989
  212. Cazzulo,J.J., Couso,R., Raimondi,A., Wernstedt,C. and Hellman,U.
    Further characterization and partial amino acid sequence of a cysteine proteinase from Trypanosoma cruzi
    Mol Biochem Parasitol (1989) 33, 33-41. PubMed  Europe PubMed
    213. 1984
  213. Bontempi,E., Franke de Cazzulo,B.M., Ruiz,A.M. and Cazzulo,J.J.
    Purification and some properties of an acidic protease from epimastigotes of Trypanosoma cruzi
    Comparative Biochemistry and Physiology B (1984) 77, 599-604. DOI
    214. 1981
  214. Rangel,H.A., Araujo,P.M., Repka,D. and Costa,M.G.
    Trypanosoma cruzi: isolation and characterization of a proteinase
    Exp Parasitol (1981) 52, 199-209. PubMed  Europe PubMed
    215. 1977
  215. Itow,S. and Camargo,E.P.
    Proteolytic activites in cell extracts of Trypanosoma cruzi
    J Protozool (1977) 24, 591-595. PubMed  Europe PubMed

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2025 EBI
Terms of use